Media about us
-
Rusnano Teams Up With U.S. Fund Domain to Invest in Life Science
06 March 2012
Russian Nanotechnologies Corp. plans to work with Domain Associates, a U.S. venture fund, to invest $760 million in U.S. life science companies and build facilities in Russia.
Shareholders
Pipeline
Media Center
-
As vaccine makers gear up for a busy season, Seqirus exec says influenza is poised for a return
18 August 2022
-
A low-toxic plant-based medicine for type 2 diabetes has been patented in the Russian Federation
18 August 2022
-
Copper coated surfaces found to reduce COVID-19 transmission
17 August 2022
-
Does terminal sterilisation affect the quality of ophthalmic APIs?
17 August 2022